3

OWNERSHIP DOCUMENT

Company: Matinas BioPharma Holdings, Inc.
Filed: April 21, 2017
Period of Report: April 3, 2017
Accession Number: 0000905718-17-000484

View Document ↗ View on SEC.gov ↗